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Objective To evaluate the prevalence and risk factors of group B streptococcus (GBS)
colonization among pregnant women and their neonates in Greece, and to examine the
serotype distribution of the GBS strains isolated and their susceptibility to antibiotics.
Methods A vaginal and a rectal swab were obtained from 1014 pregnant or parturient
women followed at public and private hospitals in Athens and in a city of northern
Greece. Cultures were also taken 24 h after birth from 428 neonates born to these women.
Results The overall maternal and neonatal colonization rates were 6.6% and 2.4%,
respectively. The vertical transmission rate was 22.5%. By logistic regression analysis,
multiparity (III) was associated with a lower colonization rate (odds ratio 4.4, 95%
confidence interval 1.08–18.63). In contrast with other studies, middle-class women
followed privately were more frequently colonized (10%) than those followed at the
public hospital (3.9%) (odds ratio 3.1, 95% confidence interval 1.83–5.42). A higher
number of prenatal visits was also associated with a higher colonization rate (change
in true odds ratio when visits increased by one, 1.3; 95% confidence interval 1.14–1.60).
No association was found between colonization and maternal age, previous obstetric
history, marital status, nationality, prematurity, Caesarean section, or infant birth weight.
The most common serotypes were II (26.9%), III (22.4%), Ia (19%), Ib (12%), and V (9%). A
considerable proportion of the isolated strains was resistant to erythromycin (4.5%),
clindamycin (6%), or both (6%).
Conclusion The rate and risk factors of maternal and neonatal GBS colonization may vary
in different communities. These rates, as well as the incidence of neonatal disease, need to
be thoroughly evaluated in each country to allow the most appropriate preventive
strategy to be selected.
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I N T R O D U C T I O N
The group B streptococcus (GBS) has been identi-
fied as the leading cause of neonatal sepsis and
meningitis in many European countries and in
North America, causing considerable morbidity
and mortality [1]. The incidence of these infections
has been estimated to be about 0.5 to three cases
per 1000 live births, and substantial geographic
and racial differences have been identified [2,3].
Administration of intrapartum antimicrobial pro-
phylaxis to colonized women has been shown to
be effective in reducing the incidence of early-
onset GBS disease in neonates [3]. Preventive
strategies were therefore developed and have
been introduced in North America and Australia,
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where these methods have been shown to be cost-
effective, given the rates of GBS disease in these
countries [4]. However, studies from other parts of
the world suggest that GBS is a less important cause
of neonatal sepsis, and Gram-negative organisms
are isolated more frequently [5]. Maternal coloniza-
tion rates have also been found to vary between
different countries or different ethnic groups within
the same country, and appear to correlate with
invasive infection rates in neonates [2,6].
The rate of GBS colonization and disease among
pregnant women and their infants has not been
studied in Greece, and no preventive strategy has
been formulated with regard to intrapartum anti-
microbial prophylaxis. The aim of this prospective,
cross-sectional study was to examine the preva-
lence and risk factors of maternal and infant colo-
nization in our area. In addition, the serogroup
distribution of GBS strains and their susceptibility
to antibiotics were also examined.
M A T E R I A L S A N D M E T H O D S
One thousand and fourteen women were exam-
ined over a 17-month period between 1 January
2000 and 31 May 2001. Of all the participants, 589
were in labor, and the rest were enrolled during a
follow-up examination at 35 weeks of gestation.
Most of the women (n ¼ 617) were examined at
the Alexandra Maternity Hospital, which is a
large, public, inner city, tertiary-care center in
Athens, and of these, 29 were cared for by a private
physician. Some women who were followed or
delivered at two private maternity hospitals in
Athens (n ¼ 181) and at two private hospitals in
the city of Drama, located in northern Greece
(n ¼ 216), were also enrolled in the study. A lower
vaginal and a rectal swab were obtained from each
subject. Cultures were also taken 24 h after birth
from the ear canal, throat and umbilicus of 428
neonates born to women who were in labor at the
time of enrollment in the study.
A standard questionnaire was filled out for each
subject participating in the study. Information was
obtained regarding demographic data, hospital of
examination, insurance, gestational age, previous
obstetric history, parity, marital status, number of
prenatal visits, mode of delivery, administration of
antibiotics during labor, neonate’s birth weight, and
the occurrence of sepsis. Oral informed consent was
obtainedfromeachpatient.Thestudywasapproved
by the Ethics Committee of the Alexandra hospital.
Microbiology
Swabs were immediately placed in transport med-
ium (Transwab, Medical Wire and Equipment Co.,
Corsham, UK) and were inoculated within 48 h in
Todd–Hewitt broth (Difco, Detroit, MI, USA) con-
taining nalidixic acid (15 mg/L) and gentamicin
(8 mg/L). After 24 h of incubation at 37 8C, sub-
cultures were performed in Columbia 5% sheep
blood agar (Sanofi Pasteur, Marmes La Coquette,
France). Colonies were identified presumptively
by colony morphology, Gram stain, and biochem-
ical methods (Api 20 Strep, bio-Merieux, Marcyl’
Etoile, France). Latex agglutination with the Strep-
tococcus grouping kit (Oxoid, Basingstoke, UK)
was used for serogroup determination. Sus-
ceptibility to antibiotics (penicillin, ceftriaxone,
erythromycin, clindamycin, vancomycin, and
chloramphenicol) was determined with a disk
diffusion method, using Mueller–Hinton agar
with 5% sheep blood. Susceptibility to penicillin,
erythromycin and clindamycin was also examined
with the Etest (AB Biodisk, Solna, Sweden), to
determine the MIC. The results of both methods
were interpreted according to the NCCLS recom-
mendations [7]. Isolates were considered to be sus-
ceptible at the following MICs (mg/L): penicillin,
0.12; erythromycin, 0.25; and clindamycin,
0.25. Isolates were considered to be resistant to
erythromycin and clindamycin at an MIC 1 mg/
L. Strains were frozen at 20 8C until serotyping
was performed with a coagglutination method,
with antisera against types I–VIII provided by the
Statens Seruminstitute, Copenhagen, Denmark.
Statistics
Subjects were divided into two groups based on
the culture results. Women who were GBS carriers
were compared to those with negative cultures
according to their demographic, socio-economic
and clinical characteristics. All 2  2 tables were
analyzed using the chi-squared test or Fisher’s
exact test. Continuous variables were compared
between subjects using one-way analysis of var-
iance (one-way ANOVA).
A linear logistic model was fitted to evaluate the
effects of all significant exposure factors observed.
The dependent variable was GBS carriage, while
the independent variables were: age, previous mis-
carriages,multiparity,maritalstatus, hospital, num-
ber of prenatal visits, nationality, and insurance.
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The level of significance was fixed at a¼5%. The
statistical analysis was carried out with the soft-
ware product SAS (SAS Institute, Cary, NC, USA),
version 8.1.
R E S U L T S
Demographics
The mean age ( SD) of the subjects examined was
26.5  5.3 years (median 27 years, range 15–46
years). The mean gestational age ( SD) at exam-
ination was 38.8  1.57 weeks (median 39 weeks,
range 31–42 weeks). Of the 1014 women, 812 (80%)
were Greek, 136 (13.4%) Albanian, and 17 (1.7%)
Gypsies; 49 (4.8%) belonged to other ethnic groups.
Of all the women enrolled, 177 (13.5%) belonged to
the lowest socio-economic class; they were fol-
lowed at the public hospital, and did not have
any insurance.
Colonization rate and risk factors
GBS were isolated from 67 women, and the overall
colonization rate was 6.6%. The microorganism
was cultured from vaginal swabs in 39 of 67
(58.2%) cases, from rectal swabs in seven cases
(10.5%), and from both in 21 cases (31.3%). The
characteristics of positive and negative women are
shown in Table 1. There were no significant differ-
ences between colonized and GBS-negative
women with regard to age, marital status, pre-
vious miscarriages or abortions, gestational age at
Table 1 Characteristics of pregnant women and their neonates
Characteristic
Women with
negative cultures
GBS
carriers P-value
Odds ratio
(95% CI)
Adjusteda
odds ratio
(95% CI)
Mean maternal age
(years)  SD
26.5  5.4 26  4.3 0.536
Mother’s age < 20 14.8% 12% 0.514 1.3 (0.60–2.75)
Mean infant’s
birth weight (g)
 SD
3374  402 3337  303 0.529
Previous miscarriages 8.9% 11% 0.503 1.3 (0.56–2.86)
Multiparity (III) 14.3% 3% 0.005 5.4 (1.31–2.46) 4.5 (1.07–18.63)
Marital status
Married 95.2% 98.5% 0.358 0.3 (0.04–2.23)
Gestational age
at delivery
(weeks)SD
39  1.5 38.7  1.4 0.069
Prematurity
at delivery
(<37 weeks)
8% 9.4% 0.606 0.8 (0.31–2.20)
Caesarean section 14.3% 16.3% 0.693 1.2 (0.53–2.59)
Followed at the
public hospital,
no private
physician (n ¼ 588)
59.7% 34.3% <0.001 2.8 (1.68–4.76) 3.1 (1.82–5.41)
Followed privately
(n ¼ 426)
40.3% 65.7%
Mean number of
prenatal visits  SD
5  2 5.8  1.4 0.002 1.35b (1.13–1.60)
No insurance 14.1% 4.5% 0.025 3.5 (1.08–11.33)
Nationalityc
Greek (n ¼ 812) 79.3% 91% 0.017 2.7 (1.12–6.21)
Albanian (n ¼ 136) 13.4% 5.9% 0.065
Gypsy (n ¼ 17) 1.7% 1.5% 1.0
Other (n ¼ 49) 5% 1.5% 0.248
Infant colonization 0% 16.7% <0.001
aAfter multivariate analysis.
bEstimated change in true odds if the number of visits increased by one.
cEthnicity and insurance were not found to be significant in the multivariate analysis.
CI, confidence interval.
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examination or at delivery, rate of prematurity,
infant’s birth weight, or route of delivery. Coloni-
zation rates in the different ethnic groups were:
Greek 7.5%, Albanian 2.9%, Gypsies 5.8%, and
other 2.1%. The colonization rate was significantly
higher among Greek women compared to others
(3%) (P ¼ 0.017) (Table 1). Multiparous women
(III) were less likely to be colonized (2/138,
1.4% versus 65/876, 7.4%) (P ¼ 0.005). Women
followed privately in Athens had a higher coloni-
zation rate (28/210, 13.3%) compared to those
followed privately in northern Greece (16/216,
7.4%) and to women followed at the public hospi-
tal without a private physician, who had the low-
est rate (23/588, 3.9%) (P < 0.001). A significant
association was also found between colonization
and number of prenatal visits. The mean ( SD)
number of prenatal visits of the women with
negative cultures was 5  2, and that of those
who were colonized was 5.8  1.8 (P ¼ 0.002).
Women who belonged to the lowest socio-eco-
nomic class and had no insurance were less fre-
quently colonized (3/137, 2.2%) compared to the
rest (64/877, 7.3%) (P ¼ 0.025).
All significant exposure factors observed were
evaluated by multivariate analysis. Of these, par-
ity, hospital of examination or labor and number of
prenatal visits were found to be statistically sig-
nificant, whereas ethnicity and insurance were not
(Table 1).
Neonatal colonization and disease
In total, 380 neonates born to GBS-negative
mothers were examined, and none was colonized.
Forty-eight neonates born to carrier mothers were
examined, and nine were colonized. Thus, the
overall infant colonization rate was 2.1%, and
the rate of vertical transmission was 18.7%. GBS
were isolated from the ear canal in seven of nine
babies, from the throat in six of nine, and from the
umbilicus in four of nine. Antibiotics were given at
delivery to 51 of 380 (14.5%) GBS-negative
mothers, and to 10 of 48 (20.8%) carriers whose
neonates were examined (P ¼ 0.166), and all these
babies had negative cultures. The most common
reason for administration of intrapartum anti-
biotics was the performance of Caesarean section
(39/61), followed by prolonged rupture of mem-
branes (14/61), and prematurity (5/61). If babies
whose mothers received antibiotics were ex-
cluded, then the overall rate of colonization was
2.4% (9/369), and that of vertical transmission was
22.5% (9/40).
One of the colonized neonates developed
asymptomatic bacteremia with GBS without
complications, and was treated. Blood cultures
were examined in this infant at birth because of
a history of prolonged rupture of membranes.
Intrapartum antibiotics were not given to the
mother.
Serotype distribution
The serotype distribution of 67 GBS strains was as
follows, in descending order: I 31.4% (Ia 19.4%, Ib
12%), II 26.9%, III 22.4%, V 9%, IV 3%, VI 3%, VII
3%, and VIII 1.5% (Table 2). The nine colonized
neonates carried the same serotype as their
mothers.
Table 2 Serotype distribution and resistance to erythromycin and clindamycin of 67 GBS strains isolated from pregnant and
parturient women
Serotypes (%)
Erythromycin Clindamycin
Erythromycin
and clindamycina Total resistant (%)I R I R
Ia n ¼ 13 (19.4) 1 1 1 – – 3/13 (23)
Ib n ¼ 8 (12) – – 1 1 – 2/8 (25)
II n ¼ 18 (26.9) – – 1 – 1 2/18 (11)
III n ¼ 15 (22.4) 1 – – – 2 3/15 (20)
IV n ¼ 2 (3) – – – – – 0/2
V n ¼ 6 (9) – – – – 1 1/6(16.7)
VI n ¼ 2 (3) – – – – – 0/2
VII n ¼ 2 (3) – – – – – 0/2
VIII n ¼ 1 (1.5) – – – – – 0/1
Total n ¼ 67 3/67 (4.5) 4/67 (6) 4/67 (6) 11/67 (16.5)
aAll strains with reduced susceptibility to both antibiotics were resistant.
I, intermediate; R, resistant.
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Susceptibility to antibiotics
All strains were susceptible to penicillin, 4.5%
(3/67) were resistant to erythromycin, 6% (4/67)
were resistant to clindamycin, and 6% (4/67) were
resistant to both (Table 2). All strains were suscep-
tible to chloramphenicol and vancomycin. The
MIC results are shown in Table 3. The rates of
resistance in different serotypes are shown in
Table 2. There was no significant difference in
the rate of resistance between the different sero-
types (P ¼ 0.894).
D I S C U S S I O N
Many pregnant and parturient women from dif-
ferent geographic areas who belonged to different
socio-economic classes and ethnic groups were
examined for GBS colonization in this study. It
was estimated that, overall, about 7% of the
women and 2% of their infants were colonized
with this microorganism. The maternal coloniza-
tion rate was highest among middle-class preg-
nant women followed privately in Athens (13.3%),
and lowest in those who were followed at the
public hospital and did not have a private physi-
cian (3.9%). In a previous study conducted in
Greece, the vaginal colonization rate among mid-
dle-class non-pregnant women with vaginitis was
10%, but selective broth was not used [8]. In
another study of a small number of pregnant
women from south-western Greece, the vaginal
colonization rate was 12% [9]. Higher rates have
been reported from other industrialized countries
such as the USA and Canada, where estimates of
GBS colonization rates among pregnant women
are 15–40% [10,11]. In European countries, rates
between 7% and 28% have been observed [12–17].
In the developing world, low rates of maternal
colonization have been reported from some coun-
tries, and higher rates from others [6,18,19]. The
overall colonization rate was low in this study,
despite the examination of multiple sites and the
use of adequate microbiological techniques. It is
possible that genetic, social and cultural factors
may play a role in maternal GBS colonization in a
community.
The overall rate of vertical transmission was
19%, and that from infected mothers who did
not receive intrapartum antibiotics to their infants
was 22.5%. Although transmission rates range
from 29% to 85% in most studies, rates as low as
12% have been reported from countries where
low colonization rates have also been found
despite the use of adequate microbiological
methods [2,18].
Maternal colonization rates have been asso-
ciated with infection rates in newborns. Although
the data are very limited, it appears that the inci-
dence of neonatal GBS disease is lower in Greece
compared to that reported from several developed
countries, where rates between 0.5 and 3/1000
births have been noted. From 1 January 1999 to
31 December 2001, about 13 500 births took place
at the Alexandra public maternity hospital, and
only two cases of invasive GBS disease were noted,
accounting for a rate of 0.15/1000 births (unpub-
lished data). One of these two neonates was
asymptomatic, but GBS was isolated from blood
cultures drawn at birth because of prolonged rup-
ture of membranes. During the three-year period
between 1 January 1997 and 31 December 1999, ten
cases of early GBS disease were recorded among
37 823 births that took place at a large private
maternity hospital in Athens, accounting for an
incidence of 0.26/1000 births (D. Konstantinou,
personal communication). However, the incidence
of neonatal disease needs to be evaluated prospec-
tively in a large birth cohort by a separate study.
At the same time, current obstetric practices of
intrapartum antibiotic use need to be recorded and
evaluated.
Of the several risk factors examined, multiparity
(2 previous births) was associated with a low risk
Table 3 Susceptibility of 67 GBS strains isolated from pregnant and parturient women to penicillin, erythromycin and
clindamycin
Antimicrobial agent
MIC50
(mg/L)
MIC90
(mg/L)
MIC range
(mg/L)
Percentage
Susceptible Intermediate Resistant
Penicillin 0.064 0.094 0.023–0.125 100 0 0
Erythromycin 0.125 0.25 0.016–8 89.5 3 7.5
Clindamycin 0.125 0.5 0.016–4 88 4.5 7.5
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for maternal colonization, in accordance with most
previous studies [2,20]. The place of examination
and the number of prenatal visits were also asso-
ciated with GBS colonization. The results of multi-
variate analysis showed that women who were
followed privately and those with a higher num-
ber of prenatal visits were more frequently colo-
nized. These women belong to a higher socio-
economic class compared to those who seek care
at a public inner city hospital and have poor
prenatal care. This finding is in contrast with
similar studies conducted in different settings in
which GBS colonization has been found more
frequently among women of low socio-economic
class followed at public hospitals [2,20].
Serotype distribution was almost even between
I, II and III, with a slight preponderance of ser-
otype I. Serotype V, which has recently emerged as
a frequently colonizing serotype in several coun-
tries [21], accounted for a considerable proportion
of the strains (9%), ranking fourth. With the excep-
tion of serotype V, which, in our study, was half as
common, the serotype distribution found was not
much different from the one detected in a recent
study from the USA, where higher colonization
rates were observed [11]. Therefore, serotype dis-
tribution may not account for the lower coloniza-
tion rate observed in our area.
All strains examined were susceptible to peni-
cillin, but a considerable proportion was resistant
to erythromycin (10.5%) and clindamycin (12%).
The rate of erythromycin resistance compares well
with that found in a study conducted during 1991
among GBS colonizing strains isolated in Athens,
where it was 9% [22]. Increasing rates of GBS
resistance have been recently reported from devel-
oped and developing countries [23–26]. These
findings support the use of penicillin for the pre-
vention and treatment of these infections, and raise
concern about the use of erythromycin and clin-
damycin in penicillin-allergic patients.
In conclusion, maternal and neonatal GBS colo-
nization rates were found to be lower in this study
than in those reported from other developed and
from some developing countries. The risk factors
associated with maternal colonization were also
different. These findings may be related to genetic,
cultural or social factors, and indicate that the
profile of GBS colonization and infection may vary
in different communities. An accurate evaluation
of the colonization rate and, more importantly, the
neonatal invasive disease incidence is required for
the selection of the appropriate preventive strat-
egy in each country [27].
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